Sientra (NASDAQ:SIEN) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Sientra (NASDAQ:SIENGet Rating) in a research report released on Monday. The firm issued a sell rating on the medical instruments supplier’s stock.

Other equities analysts also recently issued reports about the company. Lake Street Capital dropped their target price on Sientra from $8.00 to $2.00 in a research report on Friday, September 16th. William Blair downgraded Sientra from an outperform rating to a market perform rating in a research report on Tuesday, October 25th. Finally, Craig Hallum dropped their target price on Sientra to $1.30 in a research report on Thursday, October 27th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Sientra currently has an average rating of Moderate Buy and an average price target of $5.19.

Sientra Price Performance

Shares of SIEN stock opened at $0.29 on Monday. The company has a quick ratio of 0.70, a current ratio of 1.34 and a debt-to-equity ratio of 7.28. The company has a market cap of $19.40 million, a P/E ratio of -0.27 and a beta of 1.51. Sientra has a twelve month low of $0.16 and a twelve month high of $4.55. The business has a fifty day simple moving average of $0.45 and a 200 day simple moving average of $0.77.

Institutional Investors Weigh In On Sientra

Several institutional investors and hedge funds have recently made changes to their positions in the stock. BlackRock Inc. increased its stake in shares of Sientra by 2.0% in the first quarter. BlackRock Inc. now owns 3,768,538 shares of the medical instruments supplier’s stock valued at $8,366,000 after buying an additional 74,896 shares during the period. Vanguard Group Inc. grew its stake in Sientra by 13.3% during the first quarter. Vanguard Group Inc. now owns 3,106,395 shares of the medical instruments supplier’s stock worth $6,896,000 after purchasing an additional 364,180 shares during the period. AWM Investment Company Inc. grew its stake in Sientra by 9.3% during the second quarter. AWM Investment Company Inc. now owns 2,190,990 shares of the medical instruments supplier’s stock worth $1,835,000 after purchasing an additional 187,006 shares during the period. Millennium Management LLC grew its stake in Sientra by 253.4% during the second quarter. Millennium Management LLC now owns 1,989,323 shares of the medical instruments supplier’s stock worth $1,666,000 after purchasing an additional 1,426,343 shares during the period. Finally, First Light Asset Management LLC grew its stake in Sientra by 11.3% during the first quarter. First Light Asset Management LLC now owns 1,789,359 shares of the medical instruments supplier’s stock worth $3,972,000 after purchasing an additional 181,010 shares during the period. Institutional investors and hedge funds own 68.40% of the company’s stock.

Sientra Company Profile

(Get Rating)

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Further Reading

Analyst Recommendations for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.